Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Kobari
Observed names:
Y. Kobari,
YUKI KOBARI
Institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University
Observed institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University
ORCID:
0000-0002-1407-2588
Observed ORCID:
0000-0002-1407-2588
OpenAlex ID:
A5009654389
Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma
2021
·
Yudai Ishiyama
, Tsunenori Kondo
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
27
Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
2021
·
YUDAI ISHIYAMA
, TSUNENORI KONDO
, et al.
·
Anticancer Research
·
26
PDF
Rapid Progressive Disease After Nivolumab Therapy in Three Patients with Metastatic Renal Cell Carcinoma
2017
·
YUKI KOBARI
, TSUNENORI KONDO
, et al.
·
In Vivo
·
26
PDF
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data
2024
·
Hiroki Ishihara
, Kenji Omae
, et al.
·
International Journal of Clinical Oncology
·
20
Comparison of postoperative recovery after robot‐assisted partial nephrectomy of T1 renal tumors through retroperitoneal or transperitoneal approach: A Japanese single institutional analysis
2020
·
Yuki Kobari
, Toshio Takagi
, et al.
·
International Journal of Urology
·
16
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up
2024
·
Hiroki Ishihara
, Nemoto Yuki
, et al.
·
Japanese Journal of Clinical Oncology
·
12
PDF
Robot‐assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease
2022
·
Kazuhiko Yoshida
, Yuki Kobari
, et al.
·
International Journal of Urology
·
11
Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma
2021
·
YUKI KOBARI
, KAZUHIKO YOSHIDA
, et al.
·
In Vivo
·
8
PDF
Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab
2024
·
CHIKA NAGAHISA
, KAZUHIKO YOSHIDA
, et al.
·
Anticancer Research
·
7
Effectiveness of Retzius-Sparing Robot-Assisted Radical Prostatectomy in a Renal Transplant Recipient: a Case Report
2022
·
Yuki Kobari
, Junpei Iizuka
, et al.
·
Transplantation Proceedings
·
7
Robot-assisted Partial Nephrectomy With Selective Artery Clamping for Renal Cell Carcinoma in Horseshoe Kidney
2024
·
YUKI KOBARI
, KAZUHIKO YOSHIDA
, et al.
·
In Vivo
·
6
PDF
Surgical and functional outcomes of repeat robot‐assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy
2023
·
Kazuhiko Yoshida
, Nao Oida
, et al.
·
International Journal of Urology
·
6
PDF
Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report
2015
·
Yuki Kobari
, Toshio Takagi
, et al.
·
World Journal of Surgical Oncology
·
6
PDF
Comparing surgical outcomes between robot-assisted laparoscopic and open partial nephrectomy for allograft kidney tumors: a retrospective, single-center study
2025
·
Taro Banno
, Yuki Kobari
, et al.
·
BMC Surgery
·
5
Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report
2023
·
YUKI KOBARI
, KAZUHIKO YOSHIDA
, et al.
·
In Vivo
·
5
PDF
Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report
2025
·
TAKAFUMI MIZUNO
, YUKI KOBARI
, et al.
·
Cancer Diagnosis & Prognosis
·
4
PDF
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial
2025
·
KAZUTAKA NAKAMURA
, YUKI KOBARI
, et al.
·
In Vivo
·
4
PDF
Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis
2024
·
Kazuhiko Yoshida
, Naoki Nagasaka
, et al.
·
International Journal of Clinical Oncology
·
4
Higher risk of intraoperative bleeding in right‐sided renal tumors compared to left‐sided tumors in robot‐assisted partial nephrectomy
2023
·
Hidekazu Tachibana
, Yuki Kobari
, et al.
·
Asian Journal of Endoscopic Surgery
·
4
Analyses of operative time according to procedure phases during robot‐assisted laparoscopic partial nephrectomy using the iPhone application “My Intuitives”
2022
·
Toshio Takagi
, Kazuhiko Yoshida
, et al.
·
International Journal of Urology
·
4
Comparison of surgical outcomes of robot-assisted laparoscopic partial nephrectomy performed by a single experienced surgeon according to two reconstruction methods, including single-layer and double-layer renorrhaphy
2024
·
Toshio Takagi
, Kazuhiko Yoshida
, et al.
·
Journal of Robotic Surgery
·
3
PDF
Safety of Docetaxel in a Patient with Metastatic Castration-Resistant Prostate Cancer After Kidney Transplantation: A Case Report
2024
·
Chika Nagahisa
, Junpei Iizuka
, et al.
·
Transplantation Proceedings
·
3
Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases
2023
·
CHIKA NAGAHISA
, JUNPEI IIZUKA
, et al.
·
In Vivo
·
3
PDF
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
2025
·
Yuki Kobari
, Junpei Iizuka
, et al.
·
Anticancer Research
·
2
PDF
Safety and efficacy of enfortumab vedotin for locally advanced or metastatic urothelial carcinoma in patients aged 80 years and older: A multicenter retrospective study in Japan
2025
·
Yuki Kobari
, Junpei Iizuka
, et al.
·
Journal of Geriatric Oncology
·
2
Show more works
View as search
Works count:
52
Citation count:
229
H-index:
8
I10-index:
7
Year
Topic
Type